| P2093 | author name string | Lotz M | |
| | Quach J | |
| | Kühn K | |
| | Komuro H | |
| | Brinson DC | |
| | Olee T | |
| | Valbracht J | |
| | Creighton-Achermann L | |
| | Shikhman A | |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src | Q28142620 |
| | Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival | Q28142897 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy | Q33565653 |
| | The role of the chondrocyte in osteoarthritis | Q34051076 |
| | Osteoprotegerin ligand: a regulator of immune responses and bone physiology. | Q34079327 |
| | The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis | Q34169053 |
| | IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion | Q37202023 |
| | Abnormal cancellous bone collagen metabolism in osteoarthritis | Q37380621 |
| | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 |
| | The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 |
| P433 | issue | 12 | |
| P921 | main subject | cartilage | Q502730 |
| P304 | page(s) | 2768-2776 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage | |
| P478 | volume | 44 | |